This literature review updates the reader on the new studies regarding steroid therapy over
the last year in stable COPD and in exacerbations. In stable COPD, we critique the 2011 …

Clinical trials in chronic obstructive pulmonary disease (COPD) patients have shown that the
long-term use of inhaled corticosteroids (ICS) in COPD patients reduced the number of …

Chronic obstructive pulmonary disease (COPD) is a devastating illness characterized by
airway and systemic inflammation, progressive airway obstruction and exacerbations. It is a …

Inhaled corticosteroids (ICS) are the mainstay of treatment for asthma, but their role in
chronic obstructive pulmonary disease (COPD) is debated. Recent randomised controlled …

In this article, we focus on the scientific evidence from randomised trials supporting
treatment with inhaled corticosteroids (ICS) in chronic obstructive pulmonary disease …

The efficacy, safety and positioning of inhaled corticosteroids (ICS) in the treatment of
patients with chronic obstructive pulmonary disease (COPD) is much debated, since it can …

BACKGROUND: COPD guidelines report that systemic corticosteroids are preferred over
inhaled corticosteroids in the treatment of exacerbations, but the inhaled route is considered …

PURPOSE We wanted to review systematically the efficacy, effectiveness, and safety of
inhaled corticosteroids with respect to health outcomes in patients with chronic obstructive …

Background The differential risk of pneumonia among inhaled corticosteroid (ICS) use in
patients with COPD requires more investigation, especially regarding beclomethasone …

This meta-analysis compares the efficacy and safety of inhaled versus systemic
corticosteroids for COPD exacerbations. Following a pre-registered protocol, we appraised …